Figure 5
From: Gadolinium in pediatric cardiovascular magnetic resonance: what we know and how we practice
Rationale for use of particular GBCA. 37% of respondents indicated “availability (e.g. hospital contract with manufacturer)” as the most important reason, followed by “approval by pharmaceutical licensing body that most closely matches my indications” (23%). Less important reasons for particular GBCA use are “price” (13%), “side effect profile” (11%), “image quality” (10%), and “other” (6%).